Geriatric oncology: Challenges for the new century

European Journal of Cancer

Volumn 36, Issue 14, 2000, Pages 1741-1754

  Balducci, L ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

Ageing; Cancer; Challenges; Comprehensive geriatric assessment; Elderly; Geriatric oncology; Life expectancy; Pharmacokinetics

Indexed keywords

AGE; AGING; GERIATRIC CARE; HUMAN; ONCOLOGY; PRIORITY JOURNAL; REVIEW;

AGE FACTORS; AGED; AGED, 80 AND OVER; AGING; HEALTH CARE COSTS; HEALTH SERVICES FOR THE AGED; HUMANS; NEOPLASMS; PROGNOSIS;

EID: 0033870822     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(00)00169-6     Document Type: Review

References (113)

1. Yancik R.M., Ries L.A.G. Aging and cancer in America. Demographic and epidemiologic perspectives. Hematol/Oncol. Clin. N. Am. 14:2000;17-23.
2. Day JC. Population Projections in the United States by Age, Sex, Race, and Hispanic Origin: 1995-2050. Washington DC, US Bureau of the Census, Current Population Reports, 1996, 25, 1130.
3. Weitzner M.A., Haley W.E., Chen H. The family caregiver of the older cancer patient. Hematol/Oncol. Clin. N. Am. 14:2000;269-281.
4. Haley W.E., Ehrbar L.A., Schonwetter R.S. Family caregiving issues. Balducci L., Lyman G.H., Ershler W.B. Comprehensive Geriatric Oncology. 1998;805-812 Harwood Academic Publishers, London.
5. Fried L.P., Storer D.J., King D.E.et al. Diagnosis of illness presentation in the elderly. J. Am. Ger. Soc. 39:1991;117-123.
6. Balducci L. Quality of life of the older person with cancer. Drugs and Aging. 4:1994;313-324.
7. Overcash J. The case for a geriatric oncology program in a cancer center. Balducci L., Lyman G.H., Ershler W.B. Comprehensive Geriatric Oncology. 1998;813-824 Harwood Academic Publishers, London.
8. Reuben D.B., Franck J., Hirsch S.et al. A randomized clinical trial of outpatient geriatric assessment (CGA), coupled with an intervention, to increase adherence to recommendations. J. Am. Ger. Soc. 47:1999;269-276.
9. Balducci L., Extermann M. Management of cancer in the older person. a practical approach The Oncologist. 5:2000;224-237.
10. Alessi C.A., Stuck A.E., Aronow H.U.et al. The process of care in preventive in-home comprehensive geriatric assessment. J. Am. Ger. Soc. 45:1997;1044-1050.
11. Balducci L., Extermann M. Cancer and aging. an evolving panorama Hematol. Oncol. Clin. N. Am. 14:2000;1-16.
12. Silverman M.A., Zaidi U., Barnett S.et al. Cancer screening in the elderly population. Hematol. Oncol. Clin. N. Am. 14:2000;89-112.
13. Jackson S.A. The epidemiology of aging. Hazzard W.R., Blass J.P., Ettinger W.H.et al. Principles of Geriatric Medicine and Gerontology. 1999;203-225 McGraw-Hill, New York.
14. High K.P., Joiner K.A. Integrating geriatrics into clinical training, research training, board certification and continuing education in infectious diseases. meeting review and commentary Clin. Infect. Dis. 28:1999;753-756.
15. Minton S. Chemoprevention of breast cancer in the older patient. Hematol. Oncol. Clin. N. Am. 14:2000;113-130.
16. Balducci L, Hardy CL, Lyman GH. Hemopoietic reserve in older cancer patients: clinical and economical considerations. Cancer Control, Journal of the Moffitt Cancer Center 2000, in press.
17. Berlin A. The conquest of cancer. Cancer Invest. 13:1995;540-550.
18. La Vecchia C. Balducci L., Lyman G.H., Ershler W.B. Comprehensive Geriatric Oncology. 1998;19-94 Harwood Academic Publishers, London.
19. Extermann M., Aapro M. Assessment of the older cancer patient. Hematol. Oncol. Clin. N. Am. 14:2000;63-78.
20. Extermann M. Measuring comorbidity in the older cancer patient. Eur. J. Cancer. 36:2000;453-471.
21. Satariano W.A., Ragland D.R. The effect of comorbidity on 3-year survival of women with primary breast cancer. Ann. Int. Med. 120:1994;104-110.
22. Balducci L., Grey J., Grassmann D Decision analysis in older cancer patients. J. Am. Ger. Soc. Proc. 110:1990.
23. Hogan D.B., Ebly E.M., Fung T.S. Disease, disability, and age in cognitively intact seniors. results from the Canadian Study of health and aging J. Gerontol. 54A:1999;M77.
24. Cassel C.K. Money, medicine and Methusalah. Mt. Sinai. J. Med. 65:1998;237-245.
25. Duthie E. Physiology of aging. relvance to symptom perceptions and treatment tolerance Balducci L., Lyman G.H., Ershler W.B. Comprehensive Geriatric Oncology. 1998;247-262 Harwood Academic Publishers, London.
26. Ershler W.B. Interleukin-6. a cytokine for gerontologists J. Am. Ger. Soc. 41:1993;176-181.
27. Hack V., Breitkreutz R., Kinscherf R.et al. The redox status as a correlate of senescence and wasting and as a target for therapeutic intervention. Blood. 54:1998;59-67.
28. Reuben D.B., Franck J., Hirsch S.et al. A randomized clinical trial of outpatient geriatric assessment (CGA), coupled with an intervention, to increase adherence to recommendations. J. Am. Ger. Soc. 47:1999;269-276.
29. Solomon D. Consensus development panel, National Institutes of Health consensus development conference statement. geriatric assessment methods for clinical decision making J. Am. Ger. Soc. 36:1988;342-347.
30. Inouye S.K., Bogardus S.T., Charpentier P.A.et al. A multicomponent intervention to prevent delirium in hospitalized older patients. N. Engl. J. Med. 340:1999;669-674.
31. Tinetti M.E., McAvay G., Claus G.et al. A multifactorial intervention to reduce the risk of falling among elderly people living in the community. N. Engl. J. Med. 331:1994;821-827.
32. Balducci L., Stanta G. Cancer in the frail patient: a coming epidemics. Hematol. Oncol. Clin. N. Am. 14:2000;235-250.
33. Rockwood K., Stadnyk K., Macknight C.et al. A brief clinical instrument to classify frailty in elderly people. Lancet. 353:1999;205-206.
34. Inoyue S.K., Peduzzi P.N., Robison J.T.et al. Importance of functional measures in predicting mortality among older hospitalized patients. J. Am. Med. Assoc. 279:1998;1187-1193.
35. Reuben D.B., Rubenstein L.V., Hirsch S.et al. Value of functional status as predictor of mortality. Am. J. Med. 93:1992;663-669.
36. Barbeger Gateau P., Fabrigoule C., Helmer C.et al. Functional impairment in instrumental activities of daily living. an early clinical sign of dementia? J. Am. Ger. Soc. 47:1999;456-462.
37. Monfardini S., Ferrucci L., Fratino L.et al. Validation of a multidimensional evaluation scale for use in elderly cancer patients. Cancer. 77:1996;395-401.
38. Coebergh J.W.W., Janssen-Heijnen M.L.G., Razenberg P.P.A. Prevalence of co-morbidity in newly diagnosed patients with cancer. a population-based study Crit. Rev. Oncol. Hematol. 27:1998;97-100.
39. Charlson M., Szatrowski T.P., Peterson J.et al. Validation of a combined comorbidity index. J. Clin. Epidemiol. 47:1994;1245-1251.
40. Conwell Y., Forbes N.T., Cox C.et al. Validation of a measure of physical illness burden at autopsy. The cumulative illness rating scale. J. Am. Ger. Soc. 41:1993;38-41.
41. Eagles J.M., Beattie J.A.G., Restall D.B.et al. Relationship between cognitive impairment and early a death in the elderly. Br. Med. J. 300:1990;239-240.
42. Bruce M.L., Hoff R.A., Jacobs S.C.et al. The effect of cognitive impairment on 9-year mortality in a community sample. J. Gerontol. 50B:1995;289-296.
43. Bruce M.L., Leaf P.J., Rozal G.P.et al. Psychiatric Status and nine year mortality data in the new haven epidemiologic catchment area study. Am. J. Psych. 151:1994;716-721.
44. Covinsky K.E., Kahana E., Chin M.H.et al. Depressive symptoms and three year mortality in older hospitalized medical patients. Ann. Int. Med. 130:1999;563-569.
45. Freid T.R., Pollack D.M., Tinetti M.E. Factors associated with six-month mortality in recipients of community-based long-term care. J. Am. Ger. Soc. 46:1998;193-197.
46. Breuer B., Wallenstein S., Feinberg C.et al. Assessing life-expectancies of older nursing home residents. J. Am. Ger. Soc. 46:1998;954-961.
47. Flacker J.M., Kiely D.K. A practical approach to identifying mortality-related factors in established long-term care residents. J. Am. Ger. Soc. 46:1998;1012-1015.
48. Frisoni G.B., Franzoni S., Rozzini R.et al. Food intake and mortality in the frail elderly. J. Gerontol. Med. Sci. 50A:1995;M203-210.
49. Mendonca J.D. Key features of maltreatment of the infirm elderly in home setting. Can. J. Psychiatry. 41:1996;107-113.
50. Guralnik J.M., Simonsick E.M., Ferrucci L.et al. A short performance battery assessing lower extremity function. association with self reported disability and prediction of mortality and nursing home admission J. Gerontol. Med. Sci. 49A:1994;M85.
51. Jette A.M., Jette D.U., Ng J.et al. Are performance-based measures sufficiently reliable for use in multicenter trials? J. Gerontol., Med. Sci. 54A:1999;M3.
52. Rantanen T., Guralnick J.M., Foley D.et al. Midlife hand grip strength as a predictor of old age disability. J. Am. Med. Assoc. 281:1999;558-560.
53. Schenkman M., Hughes M.A., Samsa G.et al. The relative importance of strength and balance in chair rise by functionally impaired older individuals. J. Am. Ger. Soc. 44:1996;1441-1446.
54. Vinograd C.H., Lemsky C.M., Nevitt M.C.et al. Development of a physical performance and mobility examination. J. Am. Ger. Soc. 42:1994;743-749.
55. Vinograd C.H., Gerety M.B., Chung M.et al. Screening for frailty. criteria and predictors of outcome J. Am. Ger. Soc. 39:1991;778-784.
56. Henneman D. Toward an understanding of frailty. Ann. Int. Med. 130:1999;945-950.
57. Anisimov I. Age as a risk factor in multistage carcinogenesis. Balducci L., Lyman G.H., Ershler W.B. Comprehensive Geriatric Oncology. 1998;157-178 Harwood Academic Publishers, London.
58. Barbone F., Bovenzi M., Cavallieri F.et al. Air pollution and lung cancer in Trieste, Italy. Am. J. Epidemiol. 141:1995;1161-1169.
59. Laszlo Keller K., Fenske N.A., Glass L.F. Cancer of the skin in the older patient. Clin. Ger. Med. 13:1997;339-362.
60. Flowers A. Brain tumors. Balducci L., Lyman G.H., Ershler W.B. Comprehensive Geriatric Oncology. 1998;703-720 Harwood Academic Publishers, London.
61. Monfardini S., Carbone A. Non-Hodgkin's lymphomas. Balducci L., Lyman G.H., Ershler W.B. Comprehensive Geriatric Oncology. 1998;577-594 Harwood Academic Publishers, London.
62. Fernandez Pol J.A., Douglas M.G. Molecular interactions of cancer and age. Hematol. Oncol. Clin. N. Am. 14:2000;25-44.
63. DeLange T. Telomeres and senescence. ending the debate Science. 279:1998;334-335.
64. Vogt M. Independent induction of senescence by p16INK4a and p21CIP1 in spontaneously immortalized human fibroblasts. Cell. Growth. Differ. 9:1998;139-146.
65. Burns E.A., Goodwin J.S. Immunological changes of aging. Balducci L., Lyman G.H., Ershler W.B. Comprehensive Geriatric Oncology. 1998;213-222 Harwood Academic Publishers, London.
66. Minton S., Shaw G. Chemoprevention of cancer in the older person. Balducci L., Lyman G.H., Ershler W.G. Comprehensive Geriatric Oncology. 1998;Harwood Academic Publishers, London.
67. Lancet J.E., Willman C.L., Bennett J.M. Acute myelogenous leukemia and aging. clinical interactions Hematol/Oncol. Clin. N. Am. 16:2000;251-268.
68. Federico M., Vitolo U., Zinzani P.L.et al. Prognosis of follicular lymphoma. a predictive model based on a retrospective analysis of 987 cases Blood. 95:2000;783-789.
69. Preti H.A., Cabanillas F., Talpaz M.et al. Prognostic value of serum interleukin 6 in diffuse large cell lymphoma. Ann. Int. Med. 127:1997;186-194.
70. Balducci L., Silliman R.A., Baekae P. Breast cancer in the older woman. an oncological viewpoint Balducci L., Lyman G.H., Ershler W.B. Comprehensive Geriatric Oncology. 1998;618-660 Harwood Academic Publishers, London.
71. Kimmick G., Balducci L. Clinical interactions of cancer and age: breast cancer. Hematol. Oncol. Clin. N. Am. 14:2000;213-234.
72. Thigpen J.T. Ovarian cancer in the older patient. Balducci L., Lyman G.H., Ershler W.B. Comprehensive Geriatric Oncology. 1998;721-732 Harwood Academic Publishers, London.
73. Erhsler W.B. Tumor-host interaction in the experimental system. Balducci L., Lyman G.H., Ershler W.B. Comprehensive Geriatric Oncology. 1998;201-202 Harwood Academic Publishers, London.
74. Ershler W.B. A gerontologist's perspective on cancer biology and treatment. Cancer Control, Journal of the Moffitt Cancer Center. 1:1994;103-108.
75. Cohen H. Monoclonal gammopathies. a model for neoplasia in older persons Balducci L., Lyman G.H., Ershler W.B. Geriatric Oncology. 1992;92-98 JB Lippincott, Philadelphia.
76. Balducci L., Barry P. Cancer prevention in the older person. Balducci L., Lyman G.H., Ershler W.B. Comprehensive Geriatric Oncology. 1998;Harwood Academic Publishers, London.
77. Robinson B., Beghe' C. Cancer screening in older patient. Clin. Ger. Med. 13:1997;97-118.
78. Kerlikowske K., Salzamann P., Phillips K.A.et al. Continuum screening mammography in women aged 70-79 years. Impact on life expectancy and cost-effectiveness. J. Am. Med. Assoc. 282:1999;2156-2163.
79. Fox S. Screening older women for breast cancer. J Am Ger Soc 2000, in press.
80. Kemeny M. Cancer surgery in the older cancer patient. Hematol. Oncol. Clin. N. Am. 14:2000;169-192.
81. Berger D.H., Roslyn J.J. Cancer surgery in the elderly. Clin. Ger. Med. 13:1997;119-142.
82. Zachariah B., Balducci L. Radiation therapy of the older cancer patient. Hematol. Oncol. Clin. N. Am. 14:2000;131-168.
83. Olmi P., Ausili-Cefaro G.P., Balzi M. Radiotherapy in the aged. Clin. Ger. Med. 13:1997;143-168.
84. Balducci L., Corcoran M.B. Antineoplastic chemotherapy of the older cancer patient. Hematol. Oncol. Clin. N. Am. 14:2000;193-212.
85. Balducci L., Extermann M. Management of the frail person with advanced cancer. Crit. Rev. Oncol. Hematol. 33:2000;343-348.
86. Balducci L., Extermann M. Cancer chemotherapy in the older patient. what the medical oncologist needs to know Cancer. 80:1997;1317-1322.
87. Cova D., Beretta G., Balducci L. Cancer chemotherapy in the older patients. Balducci L., Lyman G.H., Ershler W.B. Comprehensive Geriatric Oncology. 1998;Harwood Academic Publishers, London.
88. Pierelli L., Perillo A., Greggi S.et al. Erythropoietin addition to granulocyte- colony stimulating factor abrogates life-threatening neutropenia and increases peripheral blood progenitor-cell mobilization after epirubicin, paclitaxel and cisplatin in combination chemotherapy. J. Clin. Oncol. 17:1999;1288-1296.
89. Ratain M.J., Schilsky R.L., Choi K.E.et al. Adaptive control of etoposide administration. impact of interpatient pharmacodynamic variability Clin. Pharmacol. Ther. 45:1989;226-233.
90. Silber J.H., Fridman M., Di Paola R.S.et al. First-cycle blood counts and subsequent neutropenia, dose reduction or delay in early stage breast cancer therapy. J. Clin. Oncol. 16:1998;2392-2400.
91. Gelman R.S., Taylor S.G. Cyclophosphamide, methotrexate and 5-fluorouracil chemotherapy in women more than 65 year old with advanced breast cancer. The elimination of age trends in toxicity by using doses based on creatinine clearance. J. Clin. Oncol. 2:1984;1406-1414.
92. Borkowski J.M., Duerr M., Donehower R.C.et al. Relation between age and clearance rate of nine investigational anticancer drugs from phase I pharmacokinetics data. Cancer Chemother. Pharmacol. 33:1994;493-496.
93. Rudd G.N., Hartley G.A., Souhani R.L. Persistence of cisplatin-induced interstrand crosslinking in peripheral blood mononuclear cells from elderly and younger individuals. Cancer Chemother. Pharmacol. 35:1995;323-326.
94. Stein B.N., Petrelli N.J., Douglass H.O.et al. Age and sex are independent predictors of 5-fluorouracil toxicity. Cancer. 75:1995;11-17.
95. Allen A. The cardiotoxicity of chemotherapeutic drugs. Semin. Oncol. 19:1992;529-542.
96. Schagen S.B., Van Dam F.S.A.M., Muller M.J.et al. Cognitive deficit after postoperative adjuvant chemotherapy for breast carcinoma. Cancer. 85:1999;640-650.
97. Rubin E.H., Andersen J.W., Berg D.T.et al. Risk factors for high dose cytarabine neurotoxicity. an analysis of a cancer and acute leukemia group B trials in patients with acute myeloid leukemia J. Clin. Oncol. 10:1992;948-953.
98. Christman K., Muss H.B., Case D.et al. Chemotherapy of metastatic breast cancer in the elderly. J. Am. Med. Assoc. 268:1992;57-62.
99. Ibrahim N., Buzdar A., Frye D.et al. Should age be a determinant factor in treating breast cancer patients with combination chemotherapy? Proc. Am. Soc. Clin. Oncol. 12:1993;68.
100. Newcomb P.A., Carbone P.P. Cancer treatment and age. patient perspectives J. Natl. Cancer Inst. 85:1993;1580-1584.
101. Giovannozzi-Bannon S., Rademaker A., Lai G.et al. Treatment tolerance of elderly cancer patients entered onto phase II clinical trials. An Illinois Cancer Center study. J. Clin. Oncol. 12:1994;2447-2452.
102. Zinzani P.G., Storti S., Zaccaria A.et al. Elderly aggressive histology non-Hodgkin's lymphoma. first line VNCOP-B regimen: experience on 350 patients Blood. 94:1999;33-38.
103. Sonneveld P., de Ridder M., van der Lelie H.et al. Comparison of doxorubicin and mitoxantrone in the treatment of elderly patients with advanced diffuse non-Hodgkin's lymphoma using CHOP vs CNOP chemotherapy. J. Clin. Oncol. 13:1995;2530-2539.
104. Gomez H., Mas L., Casanova L.et al. Elderly patients with aggressive non-Hodgkin's lymphoma treated with CHOP chemotherapy plus granulocyte-macrophage colony-stimulating factor. identification of two age subgroups with differing hematologic toxicity J. Clin. Oncol. 16:1998;2352-2358.
105. Tirelli U., Errante D., Van Glabbeke M.et al. CHOP is the standard regimen in patients >70 years of age with intermediate and high grade non-Hodgkin's lymphoma. results of a randomized study of the European Organization for the Research and Treatment of Cancer lymphoma cooperative study J. Clin. Oncol. 16:1998;27-34.
106. Bastion Y., Blay J.-Y., Divine M.et al. Elderly patients with aggressive non-Hodgkin's lymphoma. disease presentation, response to treatment and survival. A Groupe d'Etude des Lymphomes de l'Adulte Study on 453 patients older than 69 years J. Clin. Oncol. 15:1997;2945-2953.
107. Bertini M., Freilone R., Vitolo U.et al. The treatment of elderly patients with aggressive non-Hodgkin's lymphomas. feasiblity and efficacy of an intensive multidrug regimen Leukemia Lymphoma. 22:1996;483-493.
108. O'Reilly SE, Connors JM, Howdle S, et al. In search of an optimal regimen for elderly patients with advanced-stage diffuse large-cell lymphoma: results of a phase II study of P/DOCE chemotherapy. J Clin Oncol 1993, 2250-2257.
109. Armitage J.O., Potter J.F. Aggressive chemotherapy for diffuse histiocytic lymphoma in the elderly. J. Am. Ger. Soc. 32:1984;269-273.
110. Balducci L, Yates G. Proposed guidelines for the management of the older person with cancer. Oncology 2000, in press.
111. Balducci L, Lyman G. Principi di farmacoeconomia. In Racine U, ed. Ematologia Geriatrica 2000, in press.
112. Lyman G.H., Kuderer N., Balducci L. Cancer care in the elderly. Cancer Control. 5:1998;347-354.
113. Extermann M., Balducci L. Practical proposals for clinical protocols in elderly patients with cancer. Balducci L., Lyman G.H., Ershler W.B. Comprehensive Geriatric Oncology. 1998;263-269 Hardwood Academic Publishers, London.